Iht Wealth Management, LLC Alaunos Therapeutics, Inc. Transaction History

Iht Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $25,440 - $42,902	-11,564 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$3.98 - $6.2 $6,208 - $9,672	1,560 Added 15.59%	11,564 $67,000
Q1 2019 May 16, 2019	SELL	$2.0 - $4.4 $5,000 - $11,000	-2,500 Reduced 19.99%	10,004 $39,000
Q4 2018 Feb 15, 2019	BUY	$1.61 - $3.62 $20,131 - $45,264	12,504 New	12,504 $23,000
Q2 2018 Aug 13, 2018	SELL	$3.02 - $4.94 $15,100 - $24,700	-5,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $20,000 - $32,700	5,000	5,000 $21,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.